Overview

Using Vasopressor Medication to Support Blood Pressure During Intubation Procedure

Status:
Not yet recruiting
Trial end date:
2022-08-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to investigate whether protocolized vasopressor use for patients with normal blood pressure undergoing rapid sequence intubation improves hemodynamic parameters and mitigates adverse events. The hypothesis is that use of vasopressors during Rapid Sequence Intubation will prevent substantial decreases in blood pressure when compared to normal intravenous fluids.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Wright State University
Treatments:
Norepinephrine
Plasma-lyte 148
Criteria
Inclusion Criteria:

- Respiratory Failure Requiring Intubation

Exclusion Criteria:

- Pregnancy

- Patients intubated during code blue clinical scenarios

- Requiring surgical airway

- Failed intubations

- MAP less than 65 or Systolic Blood Pressure (SBP) less than 90mmHg pre-intubation

- Systolic blood pressure greater than 150mmHg

- Prisoners